Larger hospitals have more breast cancer specialists who have more experience treating different types of breast cancer, including rare forms of breast cancer. Breast cancer centers that are part of larger hospitals can also offer more services to women and men with breast cancer. Consider these factors when deciding where to receive your breast cancer care.
Comprehensive, High-Quality Breast Cancer Care
As a National Cancer Institute-designated Comprehensive Cancer Center, we offer a level of expertise found only in the top cancer centers across the country. The skills and experience of our breast cancer specialists come from working with people with breast cancer every day.
Convenient, Comfortable Locations Near You
Choosing a breast cancer center near to your home minimizes the impact your treatment has on your daily activities and your quality of life. Duke cancer centers are located throughout Cary, Raleigh, Durham, and beyond. Imaging, testing, and breast cancer treatments are available at our centers.
Clinical Trials Access
You may be eligible to participate in our breast cancer clinical trials, which can provide access to new therapies before they are approved. Duke doctors are investigating new ways to approach breast tumors, how exercise impacts treatment and survival, and how to improve the quality of our patients’ lives. They are also using new vaccines to treat different types of breast cancer, including early-stage breast cancer and HER2-positive breast cancer.
Highly Specialized Breast Cancer Clinics
We offer clinics devoted to specific types of breast cancer, different age groups, and unique healthcare needs, including sexual health and fertility issues for women in their childbearing years.
Comprehensive Support Services
Our cancer support services help minimize the side effects of treatment and help you cope with the emotional and psychological effects of diagnosis and treatment. Our breast cancer survivorship clinic offers resources to help survivors after treatment ends. View all of our breast cancer support groups in our event calendar.
Nationally Recognized Doctors
Our breast cancer specialists are included in Time magazine's annual lists of the most influential people because of their contributions to new breast cancer treatment approaches. Duke breast cancer specialists were involved in the research and development that led to the recent FDA approval of two breast cancer drugs.
- Ado-trastuzumab emtansine (Kadcyla) has been referred to as a "smart bomb" because it targets the tumor, lacks significant side effects, and offers patients a better quality of life.
- Lapatinib (Tykerb), also developed by Duke doctors and researchers, treats HER2-positive breast cancer by targeting and blocking the signals that breast tumors need to grow. It’s an added option for women whose breast cancer has stopped responding to other treatments.